Spirair is a medical device company that offers minimally invasive solutions for nasal septum deviation treatment.
Spirair has raised $12.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2025.
Spirair is headquartered in South San Francisco, United States.
Spirair is a medical device company that offers minimally invasive solutions for nasal septum deviation treatment.
Spirair is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spirair — Funding & Investors." VCBacked, August 12, 2025, https://www.vcbacked.co/company/spirair. Accessed August 7, 2026.
VCBacked. (2025). Spirair — Funding & Investors. Retrieved August 7, 2026, from https://www.vcbacked.co/company/spirair
{{cite web |title=Spirair — Funding & Investors |url=https://www.vcbacked.co/company/spirair |website=VCBacked |access-date=August 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated